These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1114485)

  • 1. The effect of defibrase on arterial thrombus formation.
    Bourgain RH; Six F
    Thromb Res; 1975 Feb; 6(2):195-200. PubMed ID: 1114485
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ecarin- defibrinating enzyme isolated from Echis carinatus - on experimental arterial thrombosis.
    Kornalík F; Hladovec J
    Thromb Res; 1975 Oct; 7(4):611-21. PubMed ID: 1198548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dose-response relationship of subcutaneously administered Arwin in patients with chronic arterial blood circulation disorders].
    Ehrly AM
    Vasa; 1975; 4(2):161-7. PubMed ID: 1136569
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombus formation in the arterial and venous circulation in hypofibrinogenemic dogs.
    Olson PS
    Eur Surg Res; 1974; 6(3):176-82. PubMed ID: 4448199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of an enzyme, thrombic type, defibrase, on the formation of the white intra-arterial thrombus].
    Bourgain RH; Six F
    C R Seances Soc Biol Fil; 1975; 169(3):709-12. PubMed ID: 129221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and sensitive test for the detection of inhibitors of Defibrase and Arwin in serum.
    Stocker K; Yeh H
    Thromb Res; 1975 Feb; 6(2):189-94. PubMed ID: 1114484
    [No Abstract]   [Full Text] [Related]  

  • 8. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
    Latallo ZS; Lopaciuk S
    Thromb Diath Haemorrh Suppl; 1973; 56():253-64. PubMed ID: 4617332
    [No Abstract]   [Full Text] [Related]  

  • 9. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis.
    Gutiérrez Díaz JA; Tolón RM; Sunkel C; Priego JG; Ortega MP
    Haemostasis; 1992; 22(4):202-10. PubMed ID: 1468723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet stimulation in rats by lambda carrageenan and fibrinogen].
    Deflandre E; Damas J
    C R Seances Soc Biol Fil; 1980; 174(6):973-6. PubMed ID: 6451274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of atromid-s on lipids and other factors which may be involved in arterial thrombosis.
    Cotton RC
    Acta Cardiol; 1972; ():Suppl 15:163-7. PubMed ID: 4542784
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
    McBane RD; Hassinger NL; Grill DE; Chesebro JH
    J Thromb Haemost; 2004 Oct; 2(10):1834-41. PubMed ID: 15456496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa.
    Kong Y; Wang Y; Yang W; Xie Z; Li Z
    J Pharmacol Sci; 2015 Apr; 127(4):462-6. PubMed ID: 25913760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].
    Ehrly AM; Breddin K
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():243-5. PubMed ID: 4450660
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
    Olsson P; Blombäck M; Egberg N; Ekeström S
    Thromb Res; 1976 Sep; 9(3):277-87. PubMed ID: 982350
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of arvin on blood platelets. In vitro and in vivo studies.
    Brown CH; Bell WR; Shreiner DP; Jackson DP
    J Lab Clin Med; 1972 May; 79(5):758-69. PubMed ID: 5018740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Induction of microthrombi through arwin infusion in the rabbit].
    Müller-Berghaus G; Hocke M; Lasch HG
    Verh Dtsch Ges Inn Med; 1972; 78():1614-6. PubMed ID: 4665622
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of platelets in hemostasis and the effects of snake venom toxins on platelet function.
    de Queiroz MR; de Sousa BB; da Cunha Pereira DF; Mamede CCN; Matias MS; de Morais NCG; de Oliveira Costa J; de Oliveira F
    Toxicon; 2017 Jul; 133():33-47. PubMed ID: 28435120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.